Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cogent Biosciences (COGT) Interest Expenses (2025 - 2026)

Cogent Biosciences' Interest Expenses history spans 2 years, with the latest figure at $1.2 million for Q1 2026.

  • Quarterly Interest Expenses changed N/A to $1.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $4.3 million through Mar 2026, changed N/A year-over-year, with the annual reading at $3.1 million for FY2025, N/A changed from the prior year.
  • Interest Expenses came in at $1.2 million for Q1 2026, down from $1.3 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.5 million in Q3 2025 to a low of $314000.0 in Q2 2025.